SkyView Investment Advisors, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1848237
SHREWSBURY, NJ
Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$828,136
-$140,650 QoQ
Shares Held
5,942
-24.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026SkyView Investment Advisors, LLC holds $5,693,586 across 8 Drug Manufacturers - General names. GILD ranks #3 (14.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,141 | $1,408,348 | |
| 2 | PFE |
Pfizer Inc
|
44,796 | $1,257,871 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
5,942 | $828,136 | |
| 4 | NVO |
Novo Nordisk A S
|
19,010 | $698,617 | |
| 5 | SNY |
Sanofi
|
11,565 | $557,201 | |
| 6 | ABBV |
AbbVie Inc.
|
1,839 | $399,964 | |
| 7 | AMGN |
Amgen Inc
|
789 | $277,609 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,210 | $265,840 |
All Filings in GILD
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $828,136 | 5,942 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $968,786 | 7,893 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $973,803 | 8,773 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $1,062,578 | 9,584 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,252,494 | 11,178 | Shares | Sole | 2025-08-15 | |
| 2024-12-31 | $724,735 | 7,846 | Shares | Sole | 2025-06-02 | |
| 2024-09-30 | $711,130 | 8,482 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $552,104 | 8,047 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $520,075 | 7,100 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $535,719 | 6,613 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $472,046 | 6,299 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $998,750 | 12,959 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,650,770 | 19,896 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $1,716,055 | 19,989 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $1,360,819 | 22,059 | Shares | Sole | 2022-11-17 | |
| 2022-06-30 | $1,192,066 | 19,286 | Shares | Sole | 2022-11-15 | |
| 2022-03-31 | $1,186,324 | 19,955 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $1,117,613 | 15,392 | Shares | Sole | 2022-02-18 | |
| 2021-09-30 | $305,593 | 4,375 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||